Veru Inc (VERU)
$0.72 -$0.00 (-0.62%) 4:33 AM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$104.50M -
Day's Range
$0.67 - $0.70 -
Volume
934,035 -
52 Week Low / High
$0.36 - $1.92 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
VERU's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 2
- Strong Buy
- 2
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $3.33
- Target Price
Company News
-
Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024 — Jan 25th, 2024
Veru Inc. MIAMI, FL, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of obesity, oncology, and viral induced acute respiratory distress syndrome, today announced it will hos...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$